IMPEL NEUROPHARMA, INC.

Company Information
Address 915 E PINE ST
SEATTLE, WA, 98122-3849

http://www.impelneuropharma.com

Information

DUNS: 827915385

# of Employees: 16


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Tool for non-invasive delivery of central nervous system drug candidates

    Amount: $1,488,709.00

    DESCRIPTION provided by applicant Impel NeuroPharma is developing a nose to brain drug delivery device to enable drugs to bypass the blood brain barrier BBB in humans This Phase II SBIR aims to ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  2. Tool for non-invasive delivery of central nervous system drug candidates

    Amount: $675,057.00

    DESCRIPTION (provided by applicant): Animal models of disease are transforming preclinical research, allowing critical insights into disease mechanisms and evaluation of new therapeutics. While the ...

    SBIRPhase I2013Department of Health and Human Services
  3. Central Nervous System Delivery of Opioid Peptides

    Amount: $149,513.00

    DESCRIPTION (provided by applicant): The primary goal of this proposal is to develop opioid peptide aerosol-compatible formulations and an intranasal drug delivery system to deliver mu/delta opioid pe ...

    SBIRPhase I2012Department of Health and Human Services
  4. Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents

    Amount: $749,641.00

    Technical Abstract Impel NeuroPharma has developed a novel non-invasive delivery system, the POD device that targets drug to the upper third of the nasal cavity which results in direct and rapid tra ...

    SBIRPhase II2011Department of Defense Office for Chemical and Biological Defense
  5. Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents

    Amount: $98,334.00

    This program plans to develop a drug delivery system that provides maximum oxime drug exposure and improve cholinesterase reactivation in the brain and tissues of central nervous system (CNS) of a war ...

    SBIRPhase I2010Office for Chemical and Biological Defense Department of Defense
  6. CNS targeted delivery of anti-HIV drugs

    Amount: $495,245.00

    DESCRIPTION (provided by applicant): This program plans to develop a drug delivery system that provides maximum drug exposure and suppress residual human immunodeficiency virus (HIV)* in the brain and ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government